Avanos Medical (AVNS) Gross Profit (2016 - 2026)
Avanos Medical's Gross Profit history spans 13 years, with the latest figure at $86.0 million for Q4 2025.
- On a quarterly basis, Gross Profit fell 12.24% to $86.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $353.9 million, a 7.19% decrease, with the full-year FY2025 number at $353.9 million, down 7.19% from a year prior.
- Gross Profit hit $86.0 million in Q4 2025 for Avanos Medical, roughly flat from $86.0 million in the prior quarter.
- Over the last five years, Gross Profit for AVNS hit a ceiling of $106.6 million in Q1 2022 and a floor of $32.3 million in Q4 2021.
- Historically, Gross Profit has averaged $91.3 million across 5 years, with a median of $93.8 million in 2024.
- Biggest five-year swings in Gross Profit: plummeted 62.66% in 2021 and later skyrocketed 218.58% in 2022.
- Tracing AVNS's Gross Profit over 5 years: stood at $32.3 million in 2021, then skyrocketed by 218.58% to $102.9 million in 2022, then decreased by 7.68% to $95.0 million in 2023, then increased by 3.16% to $98.0 million in 2024, then fell by 12.24% to $86.0 million in 2025.
- Business Quant data shows Gross Profit for AVNS at $86.0 million in Q4 2025, $86.0 million in Q3 2025, and $92.1 million in Q2 2025.